Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More
January 05, 2015 at 09:31 AM EST
Conatus Pharmaceuticals Inc (NASDAQ: CNAT) +40% - The company announced plans to report top-line results of its clinical trials of ...